PLATELET P2Y12 INHIBITOR USE AND RISK OF COLORECTAL CANCER AND RELATED DEATH

被引：0
|
作者：
Fuchs, Michael
Ha, Jane
Yan, Jane
Bottai, Matteo
Song, Mingyang
Simon, Tracey G.
Ye, Weimin
Chan, Andrew T.
Ludvigsson, Jonas F.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1148
引用
收藏
页码：S268 / S269
页数：2
相关论文
共 50 条
  • [1] Is P2Y12 inhibitor therapy associated with an increased risk of cancer?
    Kaufmann, Christoph C.
    Lyon, Alexander R.
    Wojta, Johann
    Huber, Kurt
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2019, 5 (02) : 100 - 104
  • [2] P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
    Kim, Juwon
    Jang, Woo Jin
    Lee, Wang Soo
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Choi, Jin-Ho
    Bin Song, Young
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Oh, Ju-Hyeon
    Chun, Woo Jung
    Park, Yong Hwan
    Im, Eul-Soon
    Jeong, Jin-Ok
    Cho, Byung Ryul
    Oh, Seok Kyu
    Yun, Kyeong Ho
    Cho, Deok-Kyu
    Lee, Jong-Young
    Koh, Young-Youp
    Bae, Jang-Whan
    Choi, Jae Woong
    Yoon, Hyuck Jun
    Lee, Seung Uk
    Cho, Jang Hyun
    Choi, Woong Gil
    Rha, Seung-Woon
    Hahn, Joo-Yong
    HEART, 2021, 107 (13) : 1077 - 1083
  • [3] P2Y12 receptor in platelet activation
    Kim, Soochong
    Kunapuli, Satya P.
    PLATELETS, 2011, 22 (01) : 56 - 60
  • [4] Pharmacology of the platelet P2Y12 receptor
    von Kuegelgen, Ivar
    PURINERGIC SIGNALLING, 2018, 14 : S8 - S9
  • [5] PLATELET FUNCTION P2Y12 TESTING USE IN ASSESSING THE RISK FOR HEMORRHAGE IN PATIENTS ON CLOPIDOGREL
    Taylor, Olivia
    Wang, Shan
    Liu, Kui
    Daggubati, Ramesh
    Akerman, Meredith
    CRITICAL CARE MEDICINE, 2020, 48
  • [6] Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor
    Raposeiras-Roubin, Sergio
    Abu-Assi, Emad
    Munoz-Pousa, Isabel
    Cespon-Fernandez, Maria
    Cobas-Paz, Rafael
    Caneiro-Queija, Berenice
    Lopez-Rodriguez, Elena
    Perez-Casares, Luis
    Jamhour-Chelh, Karim
    Castineira-Busto, Maria
    Barreiro-Pardal, Cristina
    Calvo-Iglesias, Francisco
    Iniguez-Romo, Andres
    THROMBOSIS RESEARCH, 2019, 174 : 51 - 58
  • [7] P2Y12 inhibitors: do they increase cancer risk?
    Fierro, Joseph J.
    Cave, Brandon
    Khouzam, Rami N.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (17)
  • [8] No effect of platelet supplementation to reverse the P2Y12 inhibitor ticagrelor: an in vitro study
    Martin, A-C
    Berndt, C.
    Gaussem, P.
    Gouin-Thibault, I
    Siguret, V
    Le Bonniec, B.
    Bachelot-Loza, C.
    Godier, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 16 - 17
  • [9] No effect of platelet supplementation to reverse the P2Y12 inhibitor ticagrelor: an in vitro study
    Martin, A. -C.
    Berndt, C.
    Gaussem, P.
    Gouin-Thibault, I.
    Siguret, V.
    Le Bonniec, B.
    Godier, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1170 - 1170
  • [10] The Function and Regulation of Platelet P2Y12 Receptor
    Li, Xiaohua
    Zhang, Guoxing
    Cao, Xia
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (01) : 199 - 216
12345